Skip to main content
Premium Trial:

Request an Annual Quote

EU Funds Respiratory Infection MDx Consortium

NEW YORK (GenomeWeb News) – Researchers in four European countries will use a €6 million ($7.5 million) grant to develop molecular diagnostic testing technology to accelerate diagnosis of respiratory tract infections, such as pneumonia, the European Commission said yesterday.

The grant will support a collaboration between scientists at the Molecular Diagnostics Research Group at the National University of Ireland, Galway; the French diagnostics firm Genewave; the Finnish biotech company Mobidiag; Assistance Publique Hopitaux de Paris; and University College London.

Funded under the European Union's Seventh Framework Programme, the Rapid Identification of Respiratory Tract Infections (RID-RTI) project aims to develop a cost-effective test that would cut the time required to diagnose a large range of respiratory tract infections from days to hours.

RTIs are among the top four major causes of morbidity and mortality worldwide, according to the World Health Organization. They can be difficult to diagnose accurately and current microbial culture-based tests typically take up to 30 hours, which can impede early and effective treatment.

"There is an urgent need for rapid diagnostic tests capable of identifying the large range of microorganisms and antibiotic resistances involved with infection," Thomas Barry, principal investigator of the MDRG at NUI Galway, said in a statement.

"Speed and accuracy are key to appropriate therapy and survival of the patient," he added. "The ultimate objective [of RID-RTI] is to develop new cost effective, user-friendly products that will be routinely used in hospitals. This could replace time-consuming and labor-intensive methods so that a diagnosis can be achieved within a couple of hours, rather than days or weeks."

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.